摘要 |
This invention provides estrogen receptor modulators of formula I, having the structure wherein R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>5</SUB>, R<SUB>6</SUB>, R<SUB>7</SUB>, R<SUB>8</SUB>, R<SUB>9</SUB>, and R<SUB>10</SUB>, are as defined in the specification, or a pharmaceutically acceptable salt thereof. |